Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: BCGitis, Wheezing, Recurrent sinusitis, and Severe varicella zoster infection and others; and common findings: Reduced total natural killer cell count. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 3 | Wheezing, Recurrent viral upper respiratory tract infections, Recurrent respiratory infections |
FCGR3A encodes Fc gamma receptor IIIa (254 aa). Receptor for the invariable Fc fragment of immunoglobulin gamma (IgG). Highest expression in Spleen (240.9 TPM) and Whole Blood (164.1 TPM).
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity is associated with mutations in the FCGR3A gene on chromosome 1.
The FCGR3A protein participates in Release of PLCG from FCGR3A, Recruitment of PLCgamma to membrane due to FCGR3A effect, and FCGR3A-mediated IL10 synthesis pathways.
FCGR3A is classified as a druggable target (Clinically Actionable, Druggable Genome, and External Side Of Plasma Membrane categories) with score 1.9.
Genetic testing for FCGR3A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity has been reported in the published literature.
Phenotype severity distribution: 8 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity.
177 publications have been identified in PubMed for autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity. Research spans Basic Science / Preclinical (31%), Epidemiology / Natural History (27%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 55 |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 1:04 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity
Blood and immune system |
3 |
Recurrent viral upper respiratory tract infections, Recurrent respiratory infections, Immunodeficiency |
Ears | 1 | Recurrent otitis media |
Disease patterns and progression | 47 | 27% |
Research summaries | 26 | 15% |
Clinical study results | 22 | 12% |
Patient case studies | 18 | 10% |
Testing and diagnosis research | 5 | 3% |
New treatment approaches | 3 | 2% |
Other research | 1 | 1% |
Bicho D (2026). [PMID: 41876981](https://pubmed.ncbi.nlm.nih.gov/41876981/). *Mol Med*. [Basic Science / Preclinical]
Elwy A (2026). [PMID: 41697746](https://pubmed.ncbi.nlm.nih.gov/41697746/). *The Journal of clinical investigation*. [Basic Science / Preclinical]
Chirila CB (2026). [PMID: 42002600](https://pubmed.ncbi.nlm.nih.gov/42002600/). *Sci Rep*. [Basic Science / Preclinical]
Hacke M (2026). [PMID: 41391018](https://pubmed.ncbi.nlm.nih.gov/41391018/). *ACS Nano*. [Basic Science / Preclinical]
Li S (2026). [PMID: 42069227](https://pubmed.ncbi.nlm.nih.gov/42069227/). *Immunol Lett*. [Basic Science / Preclinical]
Néant N (2026). [PMID: 40820336](https://pubmed.ncbi.nlm.nih.gov/40820336/). *Clin Infect Dis*. [Epidemiology / Natural History]
Ruggeri S (2026). [PMID: 41742461](https://pubmed.ncbi.nlm.nih.gov/41742461/). *Oncoimmunology*. [Basic Science / Preclinical]
Denault D (2026). [PMID: 34033323](https://pubmed.ncbi.nlm.nih.gov/34033323/). *Unknown Journal*. [Basic Science / Preclinical]
Alam MA (2026). [PMID: 41996637](https://pubmed.ncbi.nlm.nih.gov/41996637/). *Cancer Res Commun*. [Epidemiology / Natural History]
Gervais A (2026). [PMID: 41570068](https://pubmed.ncbi.nlm.nih.gov/41570068/). *Proc Natl Acad Sci U S A*. [Case Report / Case Series]